Patent · US Expired

Transdermal application form of calcium antagonists

US4777047A · kind A · utility

8Cited by

2References

5Claims

0Family size

Assignee

Godecke Akt. · DE

Inventors

Kurt Bauer
Dittmar Quade · Gundelfingen, DE
Majid Mahjour · Schwenksville, US

Key dates

Filing date	Sep 3, 1986
Grant date	Oct 11, 1988
Priority date	—
Expiry date	Sep 3, 2006

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of permeation enhancers permits the formulation of transdermal dosage forms for calcium antagonists. These dosage forms are administrable to humans and other mammals, e.g., bovines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.